Contact Dr. Lu for information about cancer treatments。聯繫盧博士，獲取有關癌症治療資訊。
David Zuckerman posted on
Basic Treatment for covid 19 infection/covid 19 vaccine illness:
Sweet Wormwood (Artemisia annua) (500mg), herb that is source of Artemisinins, ivermectin and chloroquine, can be used to kill virus, parasites, bacteria, etc. – Broad spectrum. There are no side effects. This antiparasitic plant along with a number of other anthelmintic medications might also be effective at preventing and treating all sorts of cancer. The plant can be grown yourself.
甜艾草（Artemisia annua）（500毫克），是青蒿素、伊维菌素和氯喹来源的草本植物，可用于杀死病毒、寄生虫、细菌等。 – 广谱。 没有副作用。 这种抗寄生虫植物与许多其他抗寄生虫药物一起也可能有效治疗各种癌症。
Artemisia annua and its phytocompounds have been used for ages to treat malaria, rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Currently, the World Health Organization recommends artemisinin-based combination therapy as the first-line treatment for multi-drug-resistant malaria. Due to the various research articles on the use of antimalarial drugs to treat coronaviruses, a question is raised: would A. annua and its compounds provide anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) properties?
PubMed/MEDLINE, Scopus, and Google Scholar were searched for peer-reviewed articles that investigated the antiviral effects and mechanisms of A. annua and its phytochemicals against SARS-CoVs. Particularly, articles that evidenced the herb’s role in inhibiting the coronavirus-host proteins were favored. Nineteen studies were retrieved. From these, fourteen in silico molecular docking studies demonstrated potential inhibitory properties of artemisinins against coronavirus-host proteins including 3CLPRO, S protein, N protein, E protein, cathepsin-L, helicase protein, nonstructural protein 3 (nsp3), nsp10, nsp14, nsp15, and glucose-regulated protein 78 receptor. Collectively, A. annua constituents may impede the SARS-CoV-2 attachment, membrane fusion, internalization into the host cells, and hinder the viral replication and transcription process. This is the first comprehensive overview of the application of compounds from A. annua against SARS-CoV-2/coronavirus disease 2019 (COVID-19) describing all target proteins. A. annua’s biological properties, the signaling pathways implicated in the COVID-19, and the advantages and disadvantages for repurposing A. annua compounds are discussed. The combination of A. annua’s biological properties, action on different signaling pathways and target proteins, and a multi-drug combined-therapy approach may synergistically inhibit SARS-CoV-2 and assist in the COVID-19 treatment. Also, A. annua may modulate the host immune response to better fight the infection.
Temporary stomach discomfort (less than 10 mins)
Niacin/B3 (500mg) with equal amounts Melatonin before bed
Niacin tends to make people have temporary hot flashes, itchiness – this is why we take before bed. Flush style Niacin is the only type that is effective. The flush red, hot flashes etc are the niacin working to encourage blood flow, dismantling the spike protein, etc. Take with Melatonin.
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
For dissolving amyloid fibrils sciencedirect.com/science/article/abs/pii/S1214021X1630206X
Mechanisms of lumbrokinase in protection of cerebral ischemia
Recombinant Protein Production of Earthworm Lumbrokinase for Potential Antithrombotic Application
Degradation of prion protein and reduced prion infectivity by earthworm homogenates
Quercetin binding accelerates prion fibrillation into proteinase sensitive and loosely structured amyloids